scholarly article | Q13442814 |
P2093 | author name string | Jing Li | |
Jing Wang | |||
Gang-Feng Zhang | |||
Ke-Li Su | |||
Lin-Lin Yin | |||
P2860 | cites work | CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 |
PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma | Q33553893 | ||
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803. | Q34688671 | ||
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. | Q34725978 | ||
The role of mTOR in the management of solid tumors: an overview | Q34881822 | ||
Deregulation of the G1/S-phase control in human testicular germ cell tumours | Q35132963 | ||
Modulation of cell cycle components by epigenetic and genetic events | Q36279315 | ||
Time trends of cancer incidence in urban beijing, 1998-2007 | Q36654602 | ||
Overview of systemic therapy for colorectal cancer | Q37484326 | ||
Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells | Q38465081 | ||
Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma | Q39677822 | ||
Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. | Q39711832 | ||
The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells | Q40507359 | ||
Deregulated G1-S control and energy stress contribute to the synthetic-lethal interactions between inactivation of RB and TSC1 or TSC2. | Q41135408 | ||
Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer | Q41492330 | ||
Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer | Q45885573 | ||
Evaluation of the prognostic value of pSMAD immunohistochemistry in colorectal cancer. | Q46032894 | ||
Analysis of the seventh edition of American Joint Committee on colon cancer staging | Q48791433 | ||
Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder | Q48839946 | ||
Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). | Q50335520 | ||
Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma. | Q50752792 | ||
Cell cycle proteins predict recurrence in stage II and III colon cancer. | Q53187334 | ||
Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma. | Q53243267 | ||
Sox17 regulates proliferation and cell cycle during gastric cancer progression. | Q53252327 | ||
Clinical significance of tumor suppressor PTEN in colorectal carcinoma. | Q53291653 | ||
Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. | Q53313878 | ||
The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. | Q53323747 | ||
Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma. | Q53376865 | ||
PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation. | Q55471774 | ||
The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma | Q61439445 | ||
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer | Q63444324 | ||
Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients | Q73005503 | ||
Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer | Q73235041 | ||
PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer | Q81404347 | ||
Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma | Q82466468 | ||
Expression of PTEN, cyclin D1, P27/KIP1 in invasive ductal carcinomas of the breast and correlation with clinicopathological parameters | Q82730965 | ||
The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma | Q84992843 | ||
CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer | Q86103273 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
colorectal carcinoma | Q25493920 | ||
overexpression | Q61643320 | ||
P304 | page(s) | 1543-1550 | |
P577 | publication date | 2014-07-14 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Concomitant depletion of PTEN and p27 and overexpression of cyclin D1 may predict a worse prognosis for patients with post-operative stage II and III colorectal cancer | |
P478 | volume | 8 |